News

Filter

Current filters:

Regulation

201 to 210 of 97252 results

ASH 2014: Merck reports overall response rate of 66% for its Keytruda in Hodgkin's lymphoma

ASH 2014: Merck reports overall response rate of 66% for its Keytruda in Hodgkin's lymphoma

08-12-2014

Keytruda (pembrolizumab), manufactured by pharma giant Merck & Co, has achieved an overall response rate…

KeytrudaMerck & CoOncologyPharmaceuticalResearchUSA

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

08-12-2014

US drugmaker AbbVie presented data at the American Society of Hematology’s annual meeting, demonstrating…

AbbVieOncologyPharmaceuticalResearchUSA

Positive new Ph III data for Novo Nordisk’s NovoEight in hemophilia A

08-12-2014

Danish diabetes major Novo Nordisk yesterday presented a new analysis of Phase III data demonstrating…

HematologyNovo NordiskNovoEightPharmaceuticalResearch

AstraZeneca wins in US Nexium pay-for-delay litigation

AstraZeneca wins in US Nexium pay-for-delay litigation

07-12-2014

Anglo-Swedish pharma major AstraZeneca revealed on Friday that a jury in the US District Court for the…

AstraZenecaGastro-intestinalsGenericsLegalNexiumPatentsRanbaxyUSA

Orexo presents new Ph III data for Zubsolv

07-12-2014

The US subsidiary of Swedish drug developer Orexo says that, in the ISTART Phase III study, Zubsolv (buprenorphine…

NeurologicalOrexoPharmaceuticalResearchSuboxoneZubsolv

Bayer files for European approval of hemophilia A drug BAY 81-8973

06-12-2014

German pharma major Bayer has filed an application for marketing authorization to the European Medicines…

BAY 81-8973BayerEuropeHematologyPharmaceuticalRegulation

FDA advisory panel backs Actavis’ ceftazidime-avibactam

06-12-2014

Ireland-headquartered generic drugs major Actavis says that the Anti-Infective Drugs Advisory Committee…

ActavisAntibiotics and Infectious diseasesAstraZenecaceftazidime-avibactamPharmaceuticalRegulationUSA

EMA update on review of studies performed at GVK Biosciences site in Hyderabad, India

06-12-2014

Some European Union member states have decided to suspend the marketing authorizations of medicines that…

EuropeGVK BiosciencesIndiaPharmaceuticalRegulationResearch

Turning a constraint into an enabler: transparency round-table at Veeva's commercial summit 2014

Turning a constraint into an enabler: transparency round-table at Veeva's commercial summit 2014

05-12-2014

In one of the opening sessions, cloud-based life sciences provider Veeva’s co-founder and president…

BMI SystemEuropeInterviewsPharmaceuticalRegulationVeeva

201 to 210 of 97252 results

Back to top